2-Hydroxycinnamaldehyde inhibits the epithelial-mesenchymal transition in breast cancer cells

Breast Cancer Res Treat. 2013 Feb;137(3):697-708. doi: 10.1007/s10549-012-2388-7. Epub 2013 Jan 3.

Abstract

Since epithelial-mesenchymal transition (EMT) plays a critical role in cancer progression and in maintaining cancer stem cell properties, EMT is emerging as a therapeutic target for inhibiting the metastatic progression of cancer cells. 2'-Hydroxycinnamaldehyde (HCA) and its derivative, 2'-benzoyloxycinnamaldehyde, have recently been suggested as promising therapeutic candidates for cancer treatment. The purpose of this study is to investigate the anti-metastatic effect of HCA on breast cancer and the molecular mechanisms by which HCA regulates the transcriptional program during EMT. HCA induces epithelial reversion at nanomolar concentrations by suppressing Snail via the nuclear translocalization of GSK-3β, which results in the transcriptional upregulation of E-cadherin. HCA also activates the transcription factor KLF17, which suppresses Id-1, indicating that HCA inhibits EMT by multiple transcriptional programs. Further, HCA treatment significantly inhibits lung metastasis in a mouse orthotopic breast cancer model. This study demonstrates the anti-metastatic effect of the non-toxic natural compound HCA through attenuation of EMT in a breast cancer model.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acrolein / analogs & derivatives
  • Acrolein / pharmacology
  • Animals
  • Antineoplastic Agents / pharmacology*
  • Benzoates / pharmacology
  • Breast Neoplasms / genetics
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / pathology*
  • Cadherins / genetics
  • Cadherins / metabolism
  • Cell Line, Tumor
  • Cell Movement / drug effects
  • Cell Survival / drug effects
  • Cinnamates / pharmacology*
  • Disease Models, Animal
  • Epidermal Growth Factor / pharmacology
  • Epithelial-Mesenchymal Transition / drug effects*
  • Female
  • Gene Expression Regulation, Neoplastic / drug effects
  • Humans
  • Inhibitor of Differentiation Protein 1 / genetics
  • Inhibitor of Differentiation Protein 1 / metabolism
  • MCF-7 Cells
  • Mice
  • Neoplasm Metastasis
  • Snail Family Transcription Factors
  • Transcription Factors / antagonists & inhibitors
  • Transcription Factors / genetics
  • Transcription Factors / metabolism
  • Transcriptional Activation
  • Wnt Signaling Pathway / drug effects

Substances

  • 2'-benzoyloxycinnamaldehyde
  • Antineoplastic Agents
  • Benzoates
  • Cadherins
  • Cinnamates
  • Inhibitor of Differentiation Protein 1
  • KLF17 protein, human
  • Snail Family Transcription Factors
  • Transcription Factors
  • p-hydroxycinnamaldehyde
  • Epidermal Growth Factor
  • Acrolein